The patents and design registrations successfully obtained by the team at Potter Clarkson put the necessary IP protection in place to enable Sanandco to commercialise its product in its most commercially important territories.
Showing 343 Results
Our biotech team brought to bear their deep scientific understanding and legal experience in patent drafting and global filing and prosecution strategy to secure commercially-focussed patent protection.
As the foundation of AstraZeneca’s respiratory biologics portfolio, targeting the underlying causes of respiratory illnesses, Fasenra® (benralizumab) is a crucial product for this multinational client.
At Potter Clarkson, we have one clearly defined purpose - creating value from innovation.
Like all organisations, the UK IPO has had to make changes to the way it operates at the current time to limit the spread of Covid-19. However, it has confirmed that services will be largely unaffected, with the majority of UKIPO staff working remotely and a move to more digital forms of communication.
The future of the Unified Patent Court was dealt a further setback last week by a judgment in the German Federal Constitutional Court.